Autogenous Vaccines Market

Autogenous vaccines, also called autologous vaccines, autovaccines, ?self? or custom vaccines, are vaccines, which prepared by isolation and destruction of microorganisms in infected individuals and used to provide immunity to the same individual. Generally, indications of autogenous vaccines include resistance of pathogenic microorganisms to antibiotic treatment, ineffective therapy or immune response and lack of commercial vaccines.

Autogenous Vaccines Market contains market size and forecasts of Autogenous Vaccines in global, including the following market information:

• Global Autogenous Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Autogenous Vaccines Market Sales, 2017-2022, 2023-2028, (M Does)
• Global top five Autogenous Vaccines companies in 2021 (%)

The global Autogenous Vaccines market was valued at 445.5 million in 2021 and is projected to reach US$ 594.7 million by 2028, at a CAGR of 4.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Poultry Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autogenous Vaccines include Boehringer Ingelheim, Vaxxinova, Zoetis, Ceva Biovac, Phibro, Elanco, AniCon Labor GmbH, Cambridge Technologies and AVICARE plus, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Autogenous Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autogenous Vaccines Market, by Obejection, 2017-2022, 2023-2028 ($ Millions) & (M Does)

Global Autogenous Vaccines Market Segment Percentages, by Obejection, 2021 (%)

• Poultry
• Fishes
• Pigs & Cattle
• Other

Global Autogenous Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Does)

Global Autogenous Vaccines Market Segment Percentages, by Application, 2021 (%)

• Large Farms
• Small Farms

Global Autogenous Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Does)

Global Autogenous Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Autogenous Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Autogenous Vaccines revenues share in global market, 2021 (%)
• Key companies Autogenous Vaccines sales in global market, 2017-2022 (Estimated), (M Does)
• Key companies Autogenous Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Boehringer Ingelheim
• Vaxxinova
• Zoetis
• Ceva Biovac
• Phibro
• Elanco
• AniCon Labor GmbH
• Cambridge Technologies
• AVICARE plus
• Genova Labs
• Addison Biological Laboratory
• ACE Laboratory Services
• Deltamune
• Dyntec
• Hygieia Biological Laboratories